Published in Drug Week, December 22nd, 2006
"We are very pleased to welcome Whitehead to Arius. He brings both a wealth of capital markets experience and an extensive knowledge of the biotechnology sector," said David S. Young, president and CEO of Arius. "Warren will be a great addition to the leadership team as we build on our strong momentum and move Arius to the next phase of growth."
Whitehead has held a number of senior financial management roles in the industry, most recently as chief financial officer of Labopharm, Inc., where he lead several rounds of financing including a cross-border...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week